Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose Ranging Study of the Effects of Macroflux® PTH Compared With Macroflux® Placebo and FORTEO® in Postmenopausal Women With Osteoporosis

NCT00489918 is registered in ClinicalTrials.gov with Zosano Pharma Corporation as lead sponsor.

NCT NCT00489918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00489918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose Ranging Study of the Effects of Macroflux® PTH Compared With Macroflux® Placebo and FORTEO® in Postmenopausal Women With Osteoporosis
Lead sponsor
Zosano Pharma Corporation
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2007
Completion date
August 31, 2008
Enrollment
165 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis